Dissemination and publicity actions will be conducted in synergy with the actions for the better exploitation of the product by pharmaceutical companies.
In each action, alternative directions (plan B) will be also considered.
The assessment phase will identify deviations from the initial strategy and identify what actions should be taken to offset any differences that may arise.
In the context of the implementation of the project results, a continuous and fruitful communication between the collaborators and the Scientific Responsible of the project (Professor Theodore Tselios) will be established.
The exchanged information during meetings will be communicated to the collaborators to fulfil the project’s objectives.
The results of the project will be presented at national and international level abiding all principles of scientific ethics.
Dissemination will take place through oral or poster presentations in scientific conferences or in publications in high-impact international journals.
Moreover, the information will be of a business and commercial character with the aim of disseminating information to the business world.
The web site will provide information on the basic scientific idea and the proposal results of the project.
They will be simplified to be comprehensible by a wider audience.
The aim is the delivery of information on the future potential business use of the product. Product evaluations will be exploited in the “Business Plan”.